Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
SK Biopharmaceuticals Seals 1st Actinium-225-Based Collaborative Research Agreement with Korea Institute of Radiological and Medical Sciences as Steps Toward Becoming Global Radiopharmaceutical Therapy Player
2024-11-19 08:00
Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea's Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA Nephropathy
2024-11-19 07:40
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
2024-11-19 06:24
FinVolution Group Reports Third Quarter 2024 Unaudited Financial Results
2024-11-19 06:00
Trip.com Group Limited Reports Unaudited Third Quarter of 2024 Financial Results
2024-11-19 06:00
Tuya Reports Third Quarter 2024 Unaudited Financial Results
2024-11-19 05:05
Supermicro Delivers Direct-Liquid-Optimized NVIDIA Blackwell Solutions
2024-11-19 02:35
Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Convergence 2024
2024-11-19 02:15
Aon Launches Cyber Risk Analyzer to Mitigate Clients' Cyber Risk Exposure
2024-11-18 23:00
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
2024-11-18 22:23
Shengfeng Development Limited Announces Joint Venture with Fujian Fulai Aviation to Expand Low-Altitude Logistics Services
2024-11-18 22:15
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
2024-11-18 22:00
Caravelle International Group Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-11-18 22:00
Massimo Announces Expansion of Successful Partnership with Rural King for 2025
2024-11-18 22:00
Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
2024-11-18 21:50
Akeso Biopharma to Attend Jefferies London Healthcare Conference and Morgan Stanley 23rd Asia Pacific Summit
2024-11-18 21:16
TOYO Co., Ltd Updates on 2024 Performance, Announces Preliminary Guidance for 2025
2024-11-18 21:00
Tuya Announces Anchor Investment by 65 Equity Partners
2024-11-18 19:30
International Cement Group Becomes Largest Dry Cement Producer in Kazakhstan with New Plant
2024-11-18 19:00
China Automotive Systems Announces Share Repurchase Program Up To $5 Million
2024-11-18 19:00
1
4
5
6
7
8
3393